Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 553.93M P/E 38.36 EPS this Y -125.00% Ern Qtrly Grth -
Income 4.95M Forward P/E 26.38 EPS next Y 700.00% 50D Avg Chg 10.00%
Sales 433.14M PEG -103.32 EPS past 5Y - 200D Avg Chg 46.00%
Dividend N/A Price/Book 2.10 EPS next 5Y 2.41% 52W High Chg -35.00%
Recommedations 2.00 Quick Ratio 2.31 Shares Outstanding 131.96M 52W Low Chg 135.00%
Insider Own 33.27% ROA 2.24% Shares Float 62.16M Beta 1.57
Inst Own 44.86% ROE 1.82% Shares Shorted/Prior 8.32M/8.01M Price 4.22
Gross Margin 75.42% Profit Margin 1.14% Avg. Volume 1,081,440 Target Price 4.83
Oper. Margin 0.65% Earnings Date May 8 Volume 746,556 Change -1.63%
About Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly AM, an antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; PuraPly MZ, a micronized particulate version of PuraPly for the management of open wounds in the surgical setting; and CYGNUS Dual, a dehydrated placental tissue preserved to retain the ECM scaffold. The company's pipeline products include ReNu, a cryopreserved suspension used to support healing of soft tissues; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.

Organogenesis Holdings Inc. News
05/02/24 Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
04/16/24 Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
04/03/24 Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
03/02/24 Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations
03/02/24 Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
03/01/24 Why Organogenesis Holding Stock Plummeted by 18% Today
02/29/24 Organogenesis (ORGO) Reports Break-Even Earnings for Q4
02/29/24 Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024
02/29/24 Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
02/12/24 Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
02/08/24 Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
01/15/24 Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
01/14/24 Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years ago
10:00 AM Best Momentum Stocks to Buy for January 5th
06:39 AM New Strong Buy Stocks for January 5th
12/28/23 Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?
12/18/23 Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For Excitement
12/07/23 Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?
11/11/23 Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript
11/10/23 The recent US$46m market cap decrease is likely to have disappointed insiders invested in Organogenesis Holdings Inc. (NASDAQ:ORGO)
ORGO Chatroom

User Image CrytpoConverter Posted - 2 days ago

$ORGO well .. 😐

User Image Bend16 Posted - 2 days ago

$ORGO I’m here for renu. A family member had a two knee injections before the fda pulled it. Theres no question that it works. We paid $1500 we each injection. If it were available we would most likely get it done once a year. I’m surprised there isn’t more movement today. Is mdxg still developing their knee injection?

User Image stockregion Posted - 2 days ago

The implications of ReNu’s success extend far beyond symptom management. Organogenesis Holdings Inc., a frontrunner in the regenerative medicine landscape, has recently shared groundbreaking results from its Phase 3 clinical trial for ReNu®, a cutting-edge therapy designed for knee osteoarthritis (OA) management. The trial's positive top line data underscore a pivotal moment in pain management and regenerative medicine, showcasing a statistically significant reduction in knee OA pain and maintenance of function at six months post-treatment. This development not only marks a significant leap forward for Organogenesis but also opens up new vistas in addressing the widespread issue of knee OA with an innovative, non-surgical option. $ORGO https://stockregion.app/p/therapeutics-company-achieves-promising

User Image stwit123 Posted - 3 days ago

$ORGO the data is not out yet. Coming later this month. If they show 95% reduction in womac, stock goes to $10.

User Image StatenIsland Posted - 3 days ago

$ORGO is ORGO news any good? pain reduction @6 months?? thats a long wait. and if it is good why is it only up a whopping 2 cents?

User Image _www_larval_com_ Posted - 3 days ago

$ORGO just jumped 3% higher to 5% (~2Mv) a moment ago, 05/17 options, follow for more volatility.

User Image Bio_Be_Dirty Posted - 3 days ago

$ORGO buyer at 2.6

User Image Profitrip Posted - 3 days ago

$ORGO eyen $2.5 dip scalp the 50ema on 15 min

User Image Bio_Be_Dirty Posted - 3 days ago

$ORGO huge news big market

User Image BusyMind Posted - 3 days ago

$ORGO İnteresting. Many stock with news like this made at least %50 at PM. If this cant move forward it will come back. There is a reason we dont know. But path seems not good.

User Image Krazedkujo Posted - 3 days ago

$APVO $W $HUBC $ORGO $PTON PM movers w/decent volume part 2

User Image microdude Posted - 3 days ago

$ORGO $mdxg acquition target now….

User Image shared_alerts Posted - 3 days ago

-05/02/2024- 📉 MORNING GAPPERS CONT 📈 $ORGO $ENVX $SVRE $STI ↩️

User Image GSP Posted - 3 days ago

Gap play watch list for today (so far): $ENVX $CVNA $EBS $APVO $ORGO

User Image Bullseye320 Posted - 3 days ago

$ORGO no volume on this suckaaa. Out for now with small profit 👍🤑

User Image CashRacks Posted - 3 days ago

@basscat12 @Vegas1 I remember when $ORGO was at 14 a share lmaoo

User Image basscat12 Posted - 3 days ago

$CVNA $EMS $ORGO Pre-Market Gap Up, delayed, courtesy barchart, presented here for @Vegas1 to help follow the money!

User Image CrytpoConverter Posted - 3 days ago

$ORGO fuuuuuck years what a great buy I made yesterday holy fuckin shiiit !! 💲💲💲🤑🤑🤑🥳🥳🥳💲💲💲💲

User Image OpenOutcrier Posted - 3 days ago

$ORGO (+12.7% pre) Organogenesis Holding (ORGO) Met Primary Endpoint in Phase 3 Trial of ReNu - SI https://ooc.bz/l/31971

User Image DaDisciplinedTrader Posted - 3 days ago

$ORGO wow. So called spiked to 3 50 and back to 2.80. Lol fucking Wallstreet. Does the shit ever stop literally everyday and every hour this so called stock market is open is being manipulated

User Image Profitrip Posted - 3 days ago

$ORGO vwap $2.8> 2nd scalp

User Image Bullseye320 Posted - 3 days ago

$ORGO only half million volume is surprising. Holding ok so far. Stop loss under 2.70. Needs volume after 8 am to survive and kill some shorts 🤣🤣

User Image SelectiveTrader Posted - 3 days ago

$ORGO gaping up on positive phase 3 data reducing knee pain. Over 10% short interest puts squeeze in play. My stop under 2.8 after 10am. "Phase 3 randomized control trial evaluating the safety and efficacy of ReNu, a cryopreserved amniotic suspension allograft (ASA), for the management of symptoms associated with knee osteoarthritis (OA) achieved its primary endpoint upon the analysis of positive top line data. The study demonstrated a statistically significant reduction in knee OA pain at six months" https://www.globenewswire.com/news-release/2024/05/02/2874026/0/en/Organogenesis-Achieves-Primary-Endpoint-in-Phase-3-Clinical-Trial-of-ReNu-for-Knee-Osteoarthritis.html

User Image ANTHONYMOMO Posted - 3 days ago

$APVO $1.53 so far micro float 4m new $ORGO

User Image unknownd Posted - 3 days ago

$ORGO need da volume

User Image YoloAlfred Posted - 3 days ago

$ORGO did shorts think phase 3 would fail?🤔

User Image Bullseye320 Posted - 3 days ago

$ORGO 30% float shorted wtff

User Image JFZ Posted - 3 days ago

$ORGO 👀

User Image unknownd Posted - 3 days ago

$ORGO news out

User Image DekmarTrades Posted - 3 days ago

Top Gainers this Morning from Hot News! This is a HOT WATCH LIST! $EBS $SOWG $PRSI $CVNA $ORGO $LCFY

Analyst Ratings
Cantor Fitzgerald Overweight Mar 1, 24
Cantor Fitzgerald Overweight Feb 7, 24
BTIG Buy Dec 27, 23
Morgan Stanley Equal-Weight Nov 14, 23
Morgan Stanley Equal-Weight Aug 11, 23
BTIG Buy Aug 10, 23
Morgan Stanley Equal-Weight Jun 15, 23
BTIG Buy May 24, 23
BTIG Neutral Nov 10, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ERANI ALBERT 10% Owner 10% Owner Jan 09 Sell 4.32 215,893 932,658 59,007,134 01/11/24
ERANI ALBERT 10% Owner 10% Owner Apr 12 Sell 2.0709 25,000 51,772 59,223,027 04/14/23
Grow Brian Chief Commercial Off.. Chief Commercial Officer Aug 20 Option 1.46 805 1,175 87,744 08/24/22
Leibowitz Arthur S Director Director Aug 12 Buy 4.755 3,000 14,265 70,854 08/15/22
Driscoll Michael Joseph Director Director Aug 12 Buy 4.80 5,000 24,000 25,547 08/15/22
Gillheeney Gary S. President and CEO President and CEO Jun 30 Option 0.99 505,050 500,000 903,292 07/01/22
ERANI ALBERT 10% Owner 10% Owner Jun 09 Sell 5.1 30,000 153,000 59,248,027 06/13/22
ERANI ALBERT 10% Owner 10% Owner Jun 06 Sell 5.43 170,000 923,100 59,278,027 06/08/22
Gillheeney Gary S. President and CEO President and CEO May 26 Option 0.99 226,804 224,536 507,482 05/31/22
Gillheeney Gary S. President and CEO President and CEO May 26 Sell 5.77 226,804 1,308,659 398,242 05/31/22
Gillheeney Gary S. President and CEO President and CEO May 23 Option 0.99 197,336 195,363 482,916 05/25/22
Gillheeney Gary S. President and CEO President and CEO May 23 Sell 5.73 197,336 1,130,735 398,242 05/25/22
Gillheeney Gary S. President and CEO President and CEO May 18 Option 0.99 263,689 261,052 456,896 05/20/22
Gillheeney Gary S. President and CEO President and CEO May 18 Sell 5.76 263,689 1,518,849 398,242 05/20/22
KATZ MICHAEL W 10% Owner 10% Owner May 16 Buy 6.03 10,000 60,300 70,382 05/18/22
Gillheeney Gary S. President and CEO President and CEO May 13 Option 0.99 314,837 311,689 496,320 05/17/22
Gillheeney Gary S. President and CEO President and CEO May 13 Sell 6.02 314,837 1,895,319 398,242 05/17/22
Montecalvo Antonio S. Vice President, Heal.. Vice President, Health Policy Mar 09 Option 3.46 68,504 237,024 141,725 03/11/22
Montecalvo Antonio S. Vice President, Heal.. Vice President, Health Policy Mar 09 Sell 8.46 107,436 908,909 44,289 03/11/22
KATZ MICHAEL W 10% Owner 10% Owner Dec 02 Buy 9.55 2,600 24,830 59,882 12/06/21
KATZ MICHAEL W 10% Owner 10% Owner Nov 26 Buy 9.79 2,000 19,580 56,282 11/30/21